Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2010
05/06/2010WO2010049438A2 Improved methods of using phosphoantigens for the treatment of diseases
05/06/2010WO2010048955A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
05/06/2010WO2010048724A1 Nitric oxide-releasing dressings
05/06/2010WO2010030538A3 Compounds for the treatment of hepatitis c
05/06/2010WO2010030182A3 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
05/06/2010WO2010029302A3 Compounds for treating viral infections
05/06/2010WO2010012381A8 Streptospirole derivatives
05/06/2010WO2010005513A3 Crystal structure of staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof
05/06/2010WO2009158284A9 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
05/06/2010WO2009154828A9 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
05/06/2010WO2009144278A3 Conglutin-gamma as medicament and diet supplement
05/06/2010US20100113607 Pharmaceutical Compositions
05/06/2010US20100113593 Topical fungicidal agents for treating nail disorders
05/06/2010US20100113592 Unsymmetrical aromatic ether diacids and absorbable polymers therefrom
05/06/2010US20100113566 Nucleic acid for treatment or prevention of immunodeficiency virus infection
05/06/2010US20100113549 Pyrrolidine compounds
05/06/2010US20100113542 Triazole derivative as an hsp 90 inhibitor
05/06/2010US20100113505 Amino-naphthyridine derivatives
05/06/2010US20100113501 Ophthalmic Composition Comprising Ascomycin
05/06/2010US20100113477 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
05/06/2010US20100113473 Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor
05/06/2010US20100113447 Triazole compounds that modulate hsp90 activity
05/06/2010US20100113439 Antifungal agents
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113430 Thioxanthene derivates useful to treat infectious diseases
05/06/2010US20100113429 Inhibitors of ftsz and uses thereof
05/06/2010US20100113401 Methods for synthesizing and purifying aminoalkyl tetracycline compounds
05/06/2010US20100113397 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
05/06/2010US20100113387 Fatty acids for use as a medicament
05/06/2010US20100113379 cAMP DEPENDENT INDUCTION OF AUTOPHAGY
05/06/2010US20100113376 Process for dosing self-emulsifying drug delivery systems
05/06/2010US20100113373 Antiviral supplement formulations
05/06/2010US20100113359 Dimethylphenoxy modulators of viral protease activity and/or parasitic enzyme activity
05/06/2010US20100113342 Antimicrobial kinocidin compositions and methods of use
05/06/2010US20100113334 Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
05/06/2010US20100113305 Oxazole and thiazole combinatorial libraries
05/06/2010US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
05/06/2010US20100112091 Use of ramoplanin to treat diseases associated with the use of antibiotics
05/06/2010US20100112012 Modulation of immune responses
05/06/2010US20100112007 Tuberculosis vaccine and method of using same
05/06/2010US20100112003 Bifidobacterium in the treatment of inflammatory disease
05/06/2010US20100112000 Non-tumorigenic mdck cell line for propagating viruses
05/06/2010US20100111996 Papaya Mosaic Virus-Based Vaccines for Influenza
05/06/2010US20100111995 Antigen conjugates and uses thereof
05/06/2010US20100111993 Recombinant vaccines and use thereof
05/06/2010US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women
05/06/2010US20100111989 Rsv f-protein and its use
05/06/2010US20100111976 Targeted biocides
05/06/2010US20100111937 Modulation of Toll-Like Receptor 5 Expression by Antisense Oligonucleotides
05/06/2010US20100111907 Methods and compositions for gene inactivation
05/06/2010US20100111900 Heterocyclic antiviral compounds
05/06/2010US20100111899 Materials and Methods for Immunizing Against FIV Infection
05/06/2010US20100111879 Saccharide foamable compositions
05/06/2010US20100111868 Monoclonal antibodies for neutralizing anthrax toxin
05/06/2010US20100111866 Receptor and Antigen Targeted Prodrug
05/06/2010US20100111854 Frozen compositions and methods for piercing a substrate
05/06/2010CA2742650A1 Nanoparticles of beta-lactam derivatives
05/06/2010CA2742227A1 Fatty acids for use as a medicament
05/06/2010CA2741862A1 Compositions containing delta-9-thc-amino acid esters and process of preparation
05/06/2010CA2741434A1 Drug for treating infections
05/06/2010CA2740954A1 Multivalent vaccine composition
05/06/2010CA2740135A1 Nitric oxide-releasing dressings
05/06/2010CA2736953A1 Cepharosporins having a catechol group
05/05/2010EP2182067A2 Hybrid polyketide synthases
05/05/2010EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
05/05/2010EP2181998A1 New benzothiazinone derivative and its use as antibacterial agent
05/05/2010EP2181996A1 Aminopiperidine derivatives
05/05/2010EP2181995A2 Salts and crystalline form of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-sufanyl)-acetate
05/05/2010EP2181994A1 Antimicrobial compounds
05/05/2010EP2181993A1 Antimicrobial oxazolidinone derivatives
05/05/2010EP2181985A1 Antiviral Agent
05/05/2010EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
05/05/2010EP2181714A2 Immunogenic composition for use in vaccination against staphylococcei
05/05/2010EP2181713A1 Pharmaceutical compositions for prevention or treatment of Lewis Y antigen related diseases and kits for detecting Lewis Y antigen
05/05/2010EP2181706A2 Florfenicol esters for treating bacterial infections
05/05/2010EP2181122A1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
05/05/2010EP2181121A2 Chimeric antigens
05/05/2010EP2180901A2 Conjugate purification
05/05/2010EP1790655B1 Biologically active peptides
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/05/2010EP1427817B1 Multiplication of viruses in a cell culture
05/05/2010EP1390026B1 Treatment of hpv caused diseases
05/05/2010EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
05/05/2010EP1089969B1 Stable no-delivering compounds
05/05/2010CN1981812B Chinese-medicinal preparation for treating AIDS and its production
05/05/2010CN1969646B Tea prepared by using dyers woad leaf and preparation process thereof
05/05/2010CN1947792B Method for preparing active protein composition type nano-selenium and its liquid phase storage tech.
05/05/2010CN1940060B Acidophilous milk and its use
05/05/2010CN1921867B Nucleoside phosphonate derivatives useful in the treatment of HIV infections
05/05/2010CN1921829B Patch
05/05/2010CN1919270B Composition, exract, and pharmaceutical use thereof
05/05/2010CN1919214B Monascus soft capsule and its preparation method
05/05/2010CN1910177B Substituted quinolines and their use as mycobacterial inhibitors
05/05/2010CN1907987B Entecavir acid addition salt, preparation method and use thereof
05/05/2010CN1907458B Chinese traditional medicine preparation for treating viral myocarditis
05/05/2010CN1903208B Adefovir dipivoxil oral disintegration tablets preparation method
05/05/2010CN1878767B Azole-based kinase inhibitors
05/05/2010CN1788734B Selenium sulfide nano particle additive preparing method and use
05/05/2010CN1785425B Preparation method of poly peptide vaccine for treating lefteye flounder adenolymphocele
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 1798